Disanto v. Secretary of Health and Human Services ( 2016 )


Menu:
  •        In the United States Court of Federal Claims
    OFFICE OF SPECIAL MASTERS
    No. 11-459V
    Filed: January 8, 2016
    * * * * * * * * * * * * * * * *                             UNPUBLISHED
    ANGELA DISANTO,               *
    *                             Special Master Gowen
    Petitioner,         *
    *                             Joint Stipulation on
    v.                            *                             Attorneys’ Fees and Costs.
    *
    SECRETARY OF HEALTH           *
    AND HUMAN SERVICES,           *
    *
    Respondent.         *
    *
    * * * * * * * * * * * * * * * *
    Robert J. Krakow, Law Office of Robert J. Krakow, P.C., New York, NY, for petitioner.
    Ann D. Martin, United States Department of Justice, Washington, DC, for respondent.
    DECISION ON ATTORNEYS’ FEES AND COSTS1
    On July 14, 2011, Angela Disanto (“petitioner”) filed a petition pursuant to the National
    Vaccine Injury Compensation Program.2 42 U.S.C. §§ 300aa-1 to -34 (2012). Petitioner alleged
    that as a result of receiving a Human Papillomavirus (“HPV”) vaccine on July 23, 2008 and
    October 17, 2008, she suffered encephalitis. Petition at ¶ 9, 10, 15. On September 28, 2015, the
    parties filed a stipulation in which they agreed to an award of compensation to petitioner. On
    September 29, 2015, the undersigned issued a decision adopting the parties’ stipulation for an
    1
    Because this decision contains a reasoned explanation for the undersigned’s action in this case,
    the undersigned intends to post this ruling on the website of the United States Court of Federal
    Claims, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat.
    2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2012)). As provided by Vaccine Rule
    18(b), each party has 14 days within which to request redaction “of any information furnished by
    that party: (1) that is a trade secret or commercial or financial in substance and is privileged or
    confidential; or (2) that includes medical files or similar files, the disclosure of which would
    constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b).
    2
    The National Vaccine Injury Compensation Program is set forth in Part 2 of the National
    Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended,
    42 U.S.C. §§ 300aa-1 to -34 (2012) (Vaccine Act or the Act). All citations in this decision to
    individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.
    1
    award. See Decision on J. Stip., filed Sept. 29, 2015.
    On January 8, 2016, the parties filed a stipulation concerning attorneys’ fees and costs.
    Petitioner requests a total award of attorneys’ fees and costs in the amount of $96,000.00. Stip. for
    Fees and Costs ¶ 3(a). Respondent does not object. 
    Id. at ¶
    4. In accordance with General Order
    #9, petitioner represents that she did not incur any reimbursable costs in pursuit of this claim. 
    Id. at ¶
    3(b).
    The Vaccine Act permits an award of reasonable attorneys’ fees and costs. 42 U.S.C. § 300
    aa-15(e). Based on the reasonableness of the parties’ stipulation, the undersigned GRANTS the
    request for approval and payment of attorneys’ fees and costs.
    Accordingly, an award should be made as follows:
    (1) in the form of a check jointly payable to petitioner and to petitioner’s attorney,
    Robert J. Krakow, of the Law Office of Robert J. Krakow, P.C., in the amount of
    $96,000.00.
    In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the
    court SHALL ENTER JUDGMENT in accordance herewith.3
    IT IS SO ORDERED.
    s/ Thomas L. Gowen
    Thomas L. Gowen
    Special Master
    3
    Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of
    notice renouncing the right to seek review.
    2
    

Document Info

Docket Number: 11-459

Judges: Thomas L. Gowen

Filed Date: 2/1/2016

Precedential Status: Non-Precedential

Modified Date: 2/9/2016